Kitai et al. demonstrated that topoisomerase I inhibitor topotecan triggers the secretion of DAMPs, promoting DC maturation and activating CD8+ T cell, thus delaying tumor growth in vivo [11]. This evidence concerns the gene CD8A and neoplasm.